DR. LAURENCE KEVIN TOKAZ M.D. NPI 1124060256

NPI Details

DR. Laurence Kevin Tokaz, M.D. is a medical oncology internal medicine in Austin, TX with 47 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Laurence Kevin Tokaz, M.D. NPI is 1124060256. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1979

The provider's business location address is:

4101 JAMES CASEY ST STE 100
AUSTIN, TX
ZIP 78745-325
Phone: (512) 447-2202
Fax: (512) 462-9574

The NPI 1124060256 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Reticulated (young) platelet measurement (HCPCS:85055)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Unclassified drugs (HCPCS:J3490)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Magnesium level (HCPCS:83735)
• Injection of drug or substance into vein (HCPCS:96374)
• Immunologic analysis technique on serum (HCPCS:86320)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Protein measurement, serum (HCPCS:84165)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Drawing of blood for a medical problem (HCPCS:99195)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)

The enumeration date for this NPI number is 6/12/2006 and was last updated on 2/13/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.